Shopping Cart
- Remove All
- Your shopping cart is currently empty
SRPKIN-1 is a covalent and irreversible inhibitor of SRPK1/2 (IC50s: 35.6 and 98 nM, respectively).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $1,170 | 6-8 weeks | |
25 mg | $1,969 | 6-8 weeks | |
50 mg | $2,380 | 6-8 weeks | |
100 mg | $3,100 | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | $1,289 | 6-8 weeks |
Description | SRPKIN-1 is a covalent and irreversible inhibitor of SRPK1/2 (IC50s: 35.6 and 98 nM, respectively). |
Targets&IC50 | SRPK2:98 nM, SRPK1:35.6 nM |
In vitro | SRPK-IN-1 effectively converts VEGF from pro-angiogenic to anti-angiogenic isoform. SRPKIN-1 treatment at 200 nM (10, 50, 100, 200 nM, 16 hours) obviously decreases SR protein phosphorylation at the steady-state with or without washout [1]. |
In vivo | SRPKIN-1 (50 nM, 300 nM,1 μL, 5 times) blocks angiogenesis through VEGF alternative splicing in a CNV mouse model [1]. |
Molecular Weight | 472.53 |
Formula | C27H21FN2O3S |
Cas No. | 2089226-94-6 |
Relative Density. | 1.43 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 110 mg/mL (232.79 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.